Article Details

Week In Review: Joincare Plans $300-$400 Million IPO On Swiss Exchange

Retrieved on: 2022-06-19 12:15:49

Tags for this article:

Click the tags to see associated articles and topics

Week In Review: Joincare Plans $300-$400 Million IPO On Swiss Exchange. View article details on hiswai:

Excerpt

... Inactivated Vaccine) (SVA), Comirnaty® (Pfizer/BioNTech mRNA Vaccine) (PFE) (BNTX), and Vaxzevria® (AstraZeneca Viral Vector Vaccine) (AZN).

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up